For pharmaceutical companies, biotech ventures, and generic drug companies! Consistent DS/DP manufacturing within the same facility.
We would like to introduce the contract development and manufacturing services for ADCs (Antibody-Drug Conjugates) provided by Mycenax Biotech Inc.
Mycenax's main capabilities include end-to-end biopharmaceutical development and manufacturing, contract development and manufacturing services for monoclonal antibodies (mAbs), dual/multiple specificity antibodies, ADCs, and flexible DS (drug substance) / DP (drug product) manufacturing capabilities.
Additionally, we are capable of aseptic filling finishes (vials [liquid and lyophilized], pre-filled syringes [PFS], cartridges).
【Features】
■ Operations compliant with PIC/S GMP, conforming to international regulations, with a track record of regulatory inspections.
■ Consistent DS/DP manufacturing within the same facility minimizes the need for multiple contract management, material transportation, and technology transfer.
■ We have multiple dedicated manufacturing facilities, including those for CHO, E. coli, human cell lines, and high-potency formulations, supporting the development and manufacturing of complex biopharmaceuticals.
*For more details, please download the PDF (English version) or feel free to contact us.